Cardiff Oncology, Inc.

NASDAQ:CRDF
Annual Meeting

of Shareholders

MEETING DATE

10/22/2026
DEF 14A FILED
08/26/2026
PUBLISHED
08/26/2026 8:01 pm
TIME TO PUBLISH
08/28/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:CRDF · CUSIP 14147L108 · CLASS common stock · CIK 0001213037

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

1
FOR
1
AGAINST
0
WITHHOLD
2
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Adoption and approval of an amendment to our Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our capital stock and common stock
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states additional common stock issuances may dilute stockholders’ voting rights.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Adjournment proposal
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states adjournment would allow additional time to solicit proxies for Proposal 1.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

520cc65b84ea203ce1d13882496f22dfd4c29dc99916eb2075ae16ba4dc09d09

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates